T1	Participants 630 747	METHODS 186 patients received either indomethacin 3 times daily, or rofecoxib twice, and 1 placebo, daily for 7 days.
T2	Participants 1030 1187	In the indomethacin group (n = 89), 77 patients (87%) showed no HO, 9 showed HO of grade 1 and 3 showed HO of grade 2 according to the Brooker classification
